Cleared Traditional

K130919 - SENSUS

K130919 is an FDA 510(k) clearance for SENSUS, manufactured by Neurometrix, Inc.. The device is a Class 2 Neurology device with product code GZJ cleared through the Traditional 510(k) pathway after a 90-day FDA review.

K130919 · Neurometrix, Inc. · Neurology device
Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
Jul 2013
Decision
90d
Days
Class 2
Risk

K130919 is an FDA 510(k) clearance for the SENSUS. Classified as Stimulator, Nerve, Transcutaneous, For Pain Relief (product code GZJ), Class II - Special Controls.

Submitted by Neurometrix, Inc. (Waltham, US). The FDA issued a Cleared decision on July 2, 2013 after a review of 90 days - within the typical 510(k) review window.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.5890 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Neurology review framework, consistent with the majority of Class II 510(k) submissions.

FDA 510(k) Submission Details - K130919

510(k) Number K130919 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 03, 2013
Decision Date July 02, 2013
Days to Decision 90 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
59d faster than avg
Panel avg: 149d · This submission: 90d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GZJ Device Classification - Class 2, Special Controls

Product Code GZJ Stimulator, Nerve, Transcutaneous, For Pain Relief
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.5890
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - GZJ Stimulator, Nerve, Transcutaneous, For Pain Relief

All 380
Devices cleared under the same product code (GZJ) and FDA review panel - the closest regulatory comparables to K130919.
Best-AV2 Pro-Sport(tm)
K123099 · Avazzia, Inc. · May 2014
BODIHEALTH SYSTEM
K131675 · Eprt Technologies, Inc. · Mar 2014
JIAJIAN POINTOSELECT DIGITAL
K123958 · Wuxi Jiajian Medical Instrument Co., Ltd. · Oct 2013
GEM-STIM COMBO STIMULATOR
K122948 · Gemore Technology Co, Ltd. · Dec 2012
NEURODYN RUBY MUSCLE STIMULATOR, NEURODYN AUSSIE MUSCLE STIMULATOR
K121369 · Ibramed Equipamentos Medicos · Dec 2012
STERLING MEDICAL IMPULSE 3 STIMULATOR
K121305 · Armstrong Industries, Inc. Dha Mediquip Int. Dha S · Sep 2012